Lung Cancer Screening: Complete Clinical Guide, Benefits & Recovery

Clinical Overview: Understanding Lung Cancer Screening

Lung Cancer Screening represents a cornerstone clinical program at Spica Healthcare — Grover Hospital, Bathinda. Supervised directly by Dr. Neha Gupta (Director & Senior Medical Oncologist), this evidence-based pathway integrates sub-millimeter surgical precision, advanced intraoperative 3D navigation, ISO Class-100 Laminar Airflow surgical suites, and personalized accelerated rehabilitation to restore function, eliminate pain, and maximize long-term treatment longevity.

In South-Western Punjab and adjoining regions of Haryana and Rajasthan, patients frequently encounter delayed clinical diagnoses or generalized approaches that fail to address anatomical nuances. At Spica Healthcare, every patient undergoes rigorous digital staging, ensuring that surgical interventions or targeted medical therapies are customized to individual biomechanics and oncological requirements.

Clinical Indications: When is Lung Cancer Screening Recommended?

• Adults aged 50 to 80 years with a 20 pack-year smoking history (e.g. 1 pack/day for 20 years).

• Current smokers or former smokers who have quit within the past 15 years.

• Individuals with significant occupational exposure to asbestos, silica, radon, or industrial fumes.

• Incidental lung nodule detected on a chest X-ray requiring specialized Low-Dose CT follow-up.

Step-by-Step Surgical & Clinical Pathway at Grover Hospital

Step 1: Risk Stratification & History

Assessment of pack-year smoking history, occupational exposures, and respiratory symptoms by Dr. Neha Gupta.

Step 2: Ultra Low-Dose CT Scan

Ultra-Low-Dose high-resolution non-contrast CT chest completed in a single breath-hold.

Step 3: Lung-RADS Nodule Categorization

Standardized Lung-RADS classification (1 to 4X) categorizing nodule benignity or suspicion.

Step 4: Personalized Action Roadmap

Actionable management plan: annual routine repeat (Lung-RADS 1-2) vs short-interval scan / biopsy (Lung-RADS 3-4).

Director's Signature Innovation: Preventive Lung Cancer Screening & Early Nodule Detection

Dr. Neha Gupta leads the Low-Dose CT Lung Cancer Screening Program at Spica Healthcare. Utilizing cutting-edge Low-Dose Computed Tomography (LDCT, which uses up to 90% less radiation than standard diagnostic CT scans), automated AI lung nodule volumetry, and standardized Lung-RADS classification, asymptomatic early-stage lung cancers are detected at Stage 1 when small (<1cm) and completely surgically curable, reducing lung cancer mortality by over 20%.

✔ Ultra Low-Dose CT (LDCT): Uses 90% lower radiation while delivering sub-millimeter lung parenchymal resolution

✔ Lung-RADS Standardized Scoring: Objective tracking of solid, part-solid, and ground-glass pulmonary nodules

✔ Smoking Cessation Support: Comprehensive counseling and nicotine replacement guidance

✔ Curative Stage 1 Detection: Identifies curable localized nodules years before symptoms appear

Recovery Timeline & Functional Milestones

Phase 1: Same-Day LDCT Scan (Day 1)

Specialist clinical assessment of smoking history/pack-years, 10-second Low-Dose CT scan completion.

Phase 2: Lung-RADS Reporting (Day 2 – 3)

Thoracic radiologist reporting with Lung-RADS score and AI nodule volume calculation review.

Phase 3: Annual Screening Cycle (Annual)

Annual LDCT screening reminder schedule ensuring continuous pulmonary health protection.

Frequently Asked Clinical Questions (FAQs)

Why is Low-Dose CT screening recommended for smokers?

Lung cancer often produces no symptoms until it has spread to advanced Stage 4. Annual Low-Dose CT screening detects tiny, asymptomatic Stage 1 tumors when they can be completely cured with minimally invasive keyhole surgery or stereotactic radiation.

How is a Low-Dose CT scan performed and is radiation safe?

A Low-Dose CT scan takes less than 10 seconds, requires no injections or dye (contrast), and uses only a fraction of the radiation of a normal CT scan (similar to the natural background radiation received over 6 months).

Is Lung Cancer Screening covered under Ayushman Bharat?

Yes, preventive lung cancer screening evaluations, Low-Dose CT scans, and pulmonology workups at Grover Hospital Bathinda are covered under PM-JAY Ayushman Bharat and 30+ private insurance TPAs.

100% Cashless Insurance & PM-JAY Ayushman Bharat Empanelment

At Spica Healthcare — Grover Hospital Bathinda, Lung Cancer Screening is fully covered under the Government of India's PM-JAY Ayushman Bharat scheme and over 30+ leading private insurance TPAs. Our on-campus insurance coordinator handles all pre-authorization documentation directly with your insurance company, eliminating financial delays. Families can also share digital DICOM CDs and biopsy reports via WhatsApp (+91 95013 73003) for an urgent surgical review.